Creative Planning Bio N Tech Se Transaction History

Creative Planning

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$122.57 - $153.67 $203,833 - $255,553	-1,663 Reduced 29.96%	3,887 $484,000
Q4 2022 Feb 10, 2023	SELL	$118.43 - $186.05 $525,592 - $825,689	-4,438 Reduced 44.43%	5,550 $833,000
Q3 2022 Nov 03, 2022	SELL	$127.65 - $183.11 $174,625 - $250,494	-1,368 Reduced 12.05%	9,988 $1.35 Million
Q2 2022 Aug 15, 2022	SELL	$123.25 - $186.24 $1.04 Million - $1.58 Million	-8,457 Reduced 42.68%	11,356 $1.69 Million
Q1 2022 May 16, 2022	BUY	$126.25 - $231.85 $2.5 Million - $4.59 Million	19,813 New	19,813 $3.38 Million

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.